Ling Li

机构：Ningxia Medical University, Ningxia Medical University General Hospital · ORCID：0000-0002-0087-3034

发表论文 760 篇 · 总被引 22532 次 · h-index 70

代表论文

• Nanoparticles-mediated mitochondrial relocation of lipid-lowering drugs shape energy metabolism to conquer acquired immune resistance (2025 · Drug Resistance Updates · 被引 13)
• Rational design of promoter editing confers multipathogen resistance in rice (2025 · Genome biology · 被引 13)
• Resveratrol alleviates IBD-associated neuropsychiatric comorbidities via microbiota-dependent arginine metabolism reprogramming and microglial M2 polarization through gut-brain axis (2025 · Cell Communication and Signaling · 被引 9)
• Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial (2025 · The Lancet Diabetes & Endocrinology · 被引 7)
• The Double‐Edged Sword of Gestational Insulin Resistance: Navigating Maternal Adaptation and Its Risks for Pregnancy and Offspring Health (2025 · Obesity Reviews · 被引 4)
• Dynamic biomechanical equilibrium in pelvic organ prolapse: from mechanistic insights to precision reconstruction (2025 · Frontiers in Medicine · 被引 4)